title: Preparation and comparative evaluation of sustained release metoclopramide hydrochloride matrix tablets.
abstract: Metoclopramide hydrochloride (MCP) is commonly used for the management of gastrointestinal disorders. Frequent administration and the undesired side effects (extra pyramidal symptoms) of the drug on the central nervous system due to the fluctuations of its plasma concentrations may lead to patient incompliance, and hence, improper therapy. Therefore, the present work will be devoted to formulate the drug in sustained release formulations. MCP was incorporated in 12 formulae containing different polymers and/or different polymer ratios. These polymers were hydroxypropylmethyl cellulose (HPMC), carboxymethylcellulose (CMC) and ethyl cellulose (EC). Sodium starch glycolate (SSG) was added to some formulae in different amounts in order to soften and/or disintegrate the tablets. Both direct compression and granulation techniques were used to prepare the tablets. The physical properties were found to be satisfactory for all the formulae. The dissolution profiles of the tablets were constructed using the change-over method. The drug release involved a combination of both diffusion and polymer-chain relaxation mechanisms. The time required to release 50% of MCP ranged from 1.2 to more than 8 h. Direct compression and dry granulation techniques produced sufficient sustaining of the drug release. However, the pellets made by wet granulation released MCP in about 2 h, i.e., pelletization spheronization technique was not effective in sustaining the drug.
authors: Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
authors: Sayed I
authors: SI
authors: Abdel-Rahman
authors: Gamal M
authors: GM
authors: Mahrous
authors: Mahmoud
authors: M
authors: El-Badry
keywords: Cellulosic polymers; Metoclopramide; Release kinetics; Super disintegrant; Sustained release; Tablet making techniques
references: Eur J Pharm Biopharm. 2003 May;55(3):339-44
references: 12754009
references: Farmaco. 2004 Oct;59(10):819-25
references: 15474059
references: Eur J Pharm Biopharm. 1999 Sep;48(2):149-55
references: 10469933
references: Drug Metab Dispos. 2002 Mar;30(3):336-43
references: 11854155
references: J Pharm Sci. 1963 Dec;52:1145-9
references: 14088963
references: Arzneimittelforschung. 1987 Feb;37(2):221-4
references: 3580026
references: Int J Pharm. 2001 Feb 1;213(1-2):7-12
references: 11165089